Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

But Norwich were back ahead almost immediately after the restart thanks to some dreadful defending from Stoke. Sainz passed ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

A dad was diagnosed with four of the deadliest brain tumours after feeling 'tingles' in his left arm for a month - and died ...

Norwich comfortably saw off Stoke 4-2 at Carrow Road to record their first win in four matches and reignite their bid to ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Norwich City are unbeaten across their past eight league games against Stoke City (W5 D3), scoring 3+ goals in four of those ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.